145 related articles for article (PubMed ID: 17156828)
21. The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.
Sun Y; Yang Z; Zhang Y; Xue J; Wang M; Shi W; Zhu B; Hu S; Yao Z; Pan H; Zhang Y
PLoS One; 2015; 10(1):e0116341. PubMed ID: 25617853
[TBL] [Abstract][Full Text] [Related]
22. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
23. Incidental diagnosis of endometrial carcinoma in a patient with breast cancer by FDG PET/CT.
Chang CC; Chen YW; Hou MF
Clin Nucl Med; 2007 Mar; 32(3):205-7. PubMed ID: 17314597
[No Abstract] [Full Text] [Related]
24. In vivo imaging of estrogen receptor concentration in the endometrium and myometrium using FES PET--influence of menstrual cycle and endogenous estrogen level.
Tsuchida T; Okazawa H; Mori T; Kobayashi M; Yoshida Y; Fujibayashi Y; Itoh H
Nucl Med Biol; 2007 Feb; 34(2):205-10. PubMed ID: 17307128
[TBL] [Abstract][Full Text] [Related]
25. F-18 FDG uptake in endometrial cancer.
Nakahara T; Fujii H; Ide M; Mochizuki Y; Takahashi W; Yasuda S; Shohtsu A; Kubo A
Clin Nucl Med; 2001 Jan; 26(1):82-3. PubMed ID: 11139071
[TBL] [Abstract][Full Text] [Related]
26. PET Imaging of Estrogen Receptors for Gynecological Tumors.
Tsujikawa T; Makino A; Mori T; Tsuyoshi H; Kiyono Y; Yoshida Y; Okazawa H
Clin Nucl Med; 2022 Jul; 47(7):e481-e488. PubMed ID: 35675139
[TBL] [Abstract][Full Text] [Related]
27. A rare gynecological case of paraneoplastic cerebellar degeneration discovered by FDG-PET.
Marchand V; Graveleau J; Lanctin-Garcia C; Bourbouloux E; Bridji B; Resche I; Kraeber-Bodéré F; Rousseau C
Gynecol Oncol; 2007 May; 105(2):545-7. PubMed ID: 17368524
[TBL] [Abstract][Full Text] [Related]
28. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.
Belhocine T; De Barsy C; Hustinx R; Willems-Foidart J
Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1132-9. PubMed ID: 12192557
[TBL] [Abstract][Full Text] [Related]
30. In vivo imaging of brain estrogen receptors in rats: a 16α-18F-fluoro-17β-estradiol PET study.
Khayum MA; de Vries EF; Glaudemans AW; Dierckx RA; Doorduin J
J Nucl Med; 2014 Mar; 55(3):481-7. PubMed ID: 24481026
[TBL] [Abstract][Full Text] [Related]
31. PET in breast cancer.
Flanagan FL; Dehdashti F; Siegel BA
Semin Nucl Med; 1998 Oct; 28(4):290-302. PubMed ID: 9800236
[TBL] [Abstract][Full Text] [Related]
32. Clinical Potential of Estrogen and Progesterone Receptor Imaging.
Linden HM; Peterson LM; Fowler AM
PET Clin; 2018 Jul; 13(3):415-422. PubMed ID: 30100079
[TBL] [Abstract][Full Text] [Related]
33. A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).
Peterson LM; Kurland BF; Schubert EK; Link JM; Gadi VK; Specht JM; Eary JF; Porter P; Shankar LK; Mankoff DA; Linden HM
Mol Imaging Biol; 2014 Jun; 16(3):431-40. PubMed ID: 24170452
[TBL] [Abstract][Full Text] [Related]
34. The development of estrogen and progestin radiopharmaceuticals for imaging breast cancer.
Katzenellenbogen JA; Welch MJ; Dehdashti F
Anticancer Res; 1997; 17(3B):1573-6. PubMed ID: 9179196
[TBL] [Abstract][Full Text] [Related]
35. 18F-FDG PET/CT findings of a recurrent adenocarcinoma arising from malignant transformation of abdominal wall endometriosis.
Jiang M; Chen P; Sun L; Huang Q; Wu H
Clin Nucl Med; 2015 Feb; 40(2):184-5. PubMed ID: 25546222
[TBL] [Abstract][Full Text] [Related]
36. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
37. [Perivascular epithelioid tumors: Utility of the positron emission tomography with 18F-fluorodesoxyglucose (PET-TAC FDG) in their staging and follow-up].
Navarro-Pelayo Lainez MM; Ramos-Font C; Rebollo Aguirre AC; Rodríguez-Fernández A; Llamas-Elvira JM
Rev Esp Med Nucl; 2010; 29(5):258-62. PubMed ID: 20462672
[TBL] [Abstract][Full Text] [Related]
38. Positron emission tomography imaging of oestrogen receptor-expression in endometrial stromal sarcoma supports oestrogen receptor-targeted therapy: case report and review of the literature.
van Kruchten M; Hospers GA; Glaudemans AW; Hollema H; Arts HJ; Reyners AK
Eur J Cancer; 2013 Dec; 49(18):3850-5. PubMed ID: 24007820
[TBL] [Abstract][Full Text] [Related]
39. PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma.
van Kruchten M; Glaudemans AW; de Vries EF; Beets-Tan RG; Schröder CP; Dierckx RA; de Vries EG; Hospers GA
J Nucl Med; 2012 Feb; 53(2):182-90. PubMed ID: 22241912
[TBL] [Abstract][Full Text] [Related]
40. Breast cancer models to study the expression of estrogen receptors with small animal PET imaging.
Aliaga A; Rousseau JA; Ouellette R; Cadorette J; van Lier JE; Lecomte R; Bénard F
Nucl Med Biol; 2004 Aug; 31(6):761-70. PubMed ID: 15246367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
